In vivo characterization of high basal signaling from the ghrelin receptor

Endocrinology

Volumn 150, Issue 11, 2009, Pages 4920-4930

  Petersen, Pia Steen ^a   Woldbye, David P D ^a   Madsen, Andreas Nygaard ^a   Egerod, Kristoffer L ^a   Jin, Chunyu ^a   Lang, Manja ^b   Rasmussen, Maria ^a   Beck Sickinger, Annette G ^b   Holst, Birgitte ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GHRELIN; GHRELIN RECEPTOR; MESSENGER RNA; NEUROPEPTIDE Y; STREPTOZOCIN; SUBSTANCE P [1 DEXTRO ARGININE 5 DEXTRO PHENYLALANINE 7,9 DEXTRO TRYPTOPHAN 11 LEUCINE]; UNCOUPLING PROTEIN 2;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APPETITE; ARTICLE; BODY WEIGHT; BRAIN CELL; CONTROLLED STUDY; FOOD INTAKE; GENE EXPRESSION REGULATION; HORMONE ACTION; HYPERPHAGIA; HYPOTHALAMUS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION;

ANIMALS; BODY WEIGHT; EATING; GENE EXPRESSION; HYPERPHAGIA; HYPOTHALAMUS; ION CHANNELS; MALE; MITOCHONDRIAL PROTEINS; NEUROPEPTIDE Y; RATS; RATS, WISTAR; RECEPTORS, GHRELIN; SIGNAL TRANSDUCTION; STREPTOZOCIN; UP-REGULATION;

EID: 70350291952     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2008-1638     Document Type: Article

References (50)

1. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K 1999 Ghrelin is a growth hormone-releasing acylated peptide from stomach. Nature 402:656-660 (Pubitemid 129516334)
2. Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, Matsukura S 2001 A role for ghrelin in the central regulation of feeding. Nature 409:194-198 (Pubitemid 32144284)
3. Tschö p M, Smiley DL, Heiman ML 2000 Ghrelin induces adiposity in rodents. Nature 407:908-913
4. Gnanapavan S, Kola B, Bustin SA, Morris DG, McGee P, Fairclough P, Bhattacharya S, Carpenter R, Grossman AB, Korbonits M 2002 The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab 87:2988-2991 (Pubitemid 34655375)
5. Kojima M, Hosoda H, Matsuo H, Kangawa K 2001 Ghrelin: discovery of the natural endogenous ligand for the growth hormone secretagogue receptor. Trends Endocrinol Metab 12:118-122 (Pubitemid 33714199)
6. Schwartz MW, Woods SC, Porte Jr D, Seeley RJ, Baskin DG 2000 Central nervous system control of food intake. Nature 404:661-671 (Pubitemid 30205071)
7. Zigman JM, Jones JE, Lee CE, Saper CB, Elmquist JK 2006 Expression of ghrelin receptor mRNA in the rat and the mouse brain. J Comp Neurol 494:528-548 (Pubitemid 41791000)
8. Schwartz MW, Morton GJ 2002 Obesity: keeping hunger at bay. Nature 418:595-597
9. Morton GJ, Cummings DE, Baskin DG, Barsh GS, Schwartz MW 2006 Central nervous system control of food intake and body weight. Nature 443:289-295 (Pubitemid 44435142)
10. Abizaid A, Liu ZW, Andrews ZB, Shanabrough M, Borok E, Elsworth JD, Roth RH, Sleeman MW, Picciotto MR, Tschö p MH, Gao XB, Horvath TL 2006 Ghrelin modulates the activity and synaptic input organization of midbrain dopamine neurons while promoting appetite. J Clin Invest 116:3229-3239
11. Diano S, Farr SA, Benoit SC, McNay EC, da Silva I, Horvath B, Gaskin FS, Nonaka N, Jaeger LB, Banks WA, Morley JE, Pinto S, Sherwin RS, Xu L, Yamada KA, Sleeman MW, Tschöp MH, Horvath TL 2006 Ghrelin controls hippocampal spine synapse density and memory performance. Nat Neurosci 9:381-388 (Pubitemid 43290968)
12. Jerlhag E, Egecioglu E, Dickson SL, Andersson M, Svensson L, Engel JA 2006 Ghrelin stimulates locomotor activity and accumbal dopamine-overflow via central cholinergic systems in mice: implications for its involvement in brain reward. Addict Biol 11:45-54 (Pubitemid 46696736)
13. Naleid AM, Grace MK, Cummings DE, Levine AS 2005 Ghrelin induces feeding in the mesolimbic reward pathway between the ventral tegmental area and the nucleus accumbens. Peptides 26:2274-2279
14. Nogueiras R, Wiedmer P, Perez-Tilve D, Veyrat-Durebex C, Keogh JM, Sutton GM, Pfluger PT, Castaneda TR, Neschen S, Hofmann SM, Howles PN, Morgan DA, Benoit SC, Szanto I, Schrott B, Schürmann A, Joost HG, Hammond C, Hui DY, Woods SC, Rahmouni K, Butler AA, Farooqi IS, O'Rahilly S, Rohner-Jeanrenaud F, Tschöp MH 2007 The central melanocortin system directly controls peripheral lipid metabolism. J Clin Invest 117:3475-3488 (Pubitemid 350097003)
15. Theander-Carrillo C, Wiedmer P, Cettour-Rose P, Nogueiras R, Perez-Tilve D, Pfluger P, Castaneda TR, Muzzin P, Schürmann A, Szanto I, Tschö p MH, Rohner-Jeanrenaud F 2006 Ghrelin action in the brain controls adipocyte metabolism. J Clin Invest 116:1983-1993
16. Holst B, Brandt E, Bach A, Heding A, Schwartz TW 2005 Non-peptide and Peptide growth hormone secretagogues act both as ghrelin receptor agonist and as positive or negative allosteric modulators of ghrelin signaling. Mol Endocrinol 19:2400-2411 (Pubitemid 41252832)
17. Holst B, Holliday ND, Bach A, Elling CE, Cox HM, Schwartz TW 2004Commonstructural basis for constitutive activity of the ghrelin receptor family. J Biol Chem 279:53806-53817
18. Holst B, Cygankiewicz A, Jensen TH, Ankersen M, Schwartz TW 2003 High constitutive signaling of the ghrelin receptor-identification of a potent inverse agonist. Mol Endocrinol 17:2201-2210 (Pubitemid 37352532)
19. Bouaboula M, Perrachon S, Milligan L, Canat X, Rinaldi-Carmona M, Portier M, Barth F, Calandra B, Pecceu F, Lupker J, Maffrand JP, Le Fur G, Casellas P 1997 A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1. Evidence for a new model of receptor/ligand interactions. J Biol Chem 272:22330-22339 (Pubitemid 27382869)
20. Nijenhuis WA, Oosterom J, Adan RA 2001 AgRP(83-132) acts as an inverse agonist on the human-melanocortin-4 receptor. Mol Endocrinol 15:164-171 (Pubitemid 32156049)
21. Tolle V, Low MJ 2008 In vivo evidence for inverse agonism of Agouti-related peptide in the central nervous system of proopiomelanocortin- deficient mice. Diabetes 57:86-94
22. Pantel J, Legendre M, Cabrol S, Hilal L, Hajaji Y, Morisset S, Nivot S, Vie-Luton MP, Grouselle D, de Kerdanet M, Kadiri A, Epelbaum J, Le Bouc Y, Amselem S 2006 Loss of constitutive activity of the growth hormone secretagogue receptor in familial short stature. J Clin Invest 116:760-768 (Pubitemid 43326885)
23. Srinivasan S, Lubrano-Berthelier C, Govaerts C, Picard F, Santiago P, Conklin BR, Vaisse C 2004 Constitutive activity of the melanocortin-4 receptor is maintained by its N-terminal domain and plays a role in energy homeostasis in humans. J Clin Invest 114:1158-1164 (Pubitemid 39578705)
24. Vaisse C, Clement K, Durand E, Hercberg S, Guy-Grand B, Froguel P 2000 Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. J Clin Invest 106:253-262 (Pubitemid 30483129)
25. Holst B, Schwartz TW 2006 Ghrelin receptor mutations - too little height and too much hunger. J Clin Invest 116:637-641 (Pubitemid 43326872)
26. Morisset S, Rouleau A, Ligneau X, Gbahou F, Tardivel-Lacombe J, Stark H, Schunack W, Ganellin CR, Schwartz JC, Arrang JM 2000 High constitutive activity of native H3 receptors regulates histamine neurons in brain. Nature 408:860-864 (Pubitemid 32016096)
27. Holst B, Lang M, Brandt E, Bach A, Howard A, Frimurer TM, Beck-Sickinger A, Schwartz TW 2006 Ghrelin receptor inverse agonists: identification of an active peptide core and its interaction epitopes on the receptor. Mol Pharmacol 70:936-946 (Pubitemid 44268450)
28. Lang M, Söll RM, Dürrenberger F, Dautzenberg FM, Beck-Sickinger AG 2004 Structure-activity studies of orexin a and orexin B at the human orexin 1 and orexin 2 receptors led to orexin 2 receptor selective and orexin 1 receptor preferring ligands. J Med Chem 47:1153-1160 (Pubitemid 38229117)
29. Egerod KL, Holst B, Petersen PS, Hansen JB, Mulder J, Hökfelt T, Schwartz TW 2007 GPR39 splice variants versus antisense gene LYPD1: expression and regulation in gastrointestinal tract, endocrine pancreas, liver, and white adipose tissue. Mol Endocrinol 21:1685-1698 (Pubitemid 47001091)
30. Tang-Christensen M, Vrang N, Larsen PJ 1998 Glucagon-like peptide 1(7-36) amide's central inhibition of feeding and peripheral inhibition of drinking are abolished by neonatal monosodium glutamate treatment. Diabetes 47:530-537 (Pubitemid 28160441)
31. Belsham DD 2007 Hormonal regulation of clonal, immortalized hypothalamic neurons expressing neuropeptides involved in reproduction and feeding. Mol Neurobiol 35:182-194
32. Laemmli UK 1970 Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685
33. Gelling RW, Overduin J, Morrison CD, Morton GJ, Frayo RS, Cummings DE, Schwartz MW 2004 Effect of uncontrolled diabetes on plasma ghrelin concentrations and ghrelin-induced feeding. Endocrinology 145:4575-4582 (Pubitemid 39281450)
34. Dong J, Peeters TL, De Smet B, Moechars D, Delporte C, Vanden Berghe P, Coulie B, Tang M, Depoortere I 2006 Role of endogenous ghrelin in the hyperphagia of mice with streptozotocin-induced diabetes. Endocrinology 147:2634-2642 (Pubitemid 43764597)
35. Bouman HJ, Van Wimersma Greidanus TB 1979 A rapid and simple cannulation technique for repeated sampling of cerebrospinal fluid in freely moving rats. Brain Res Bull 4:575-577
36. Kola B, Farkas I, Christ-Crain M, Wittmann G, Lolli F, Amin F, Harvey-White J, Liposits Z, Kunos G, Grossman AB, Fekete C, Korbonits M 2008 The orexigenic effect of ghrelin is mediated through central activation of the endogenous cannabinoid system. PLoS ONE 3:e1797 (Pubitemid 351917350)
37. Andrews ZB, Liu ZW, Walllingford N, Erion DM, Borok E, Friedman JM, Tschöp MH, Shanabrough M, Cline G, Shulman GI, Coppola A, Gao XB, Horvath TL, Diano S 2008 UCP2 mediates ghrelin's action on NPY/AgRP neurons by lowering free radicals. Nature 454:846-851
38. Shimizu-Albergine M, Ippolito DL, Beavo JA 2001 Down-regulation of fasting-induced cAMP response element-mediated gene induction by leptin in neuropeptide Y neurons of the arcuate nucleus. J Neurosci 21:1238-1246 (Pubitemid 32128768)
39. Liu G, Fortin JP, Beinborn M, Kopin AS 2007 Four missense mutations in the ghrelin receptor result in distinct pharmacological abnormalities. J Pharmacol Exp Ther 322:1036-1043 (Pubitemid 47295807)
40. Kim MS, Yoon CY, Park KH, Shin CS, Park KS, Kim SY, Cho BY, Lee HK 2003 Changes in ghrelin and ghrelin receptor expression according to feeding status. Neuroreport 14:1317-1320
41. Nogueiras R, Tovar S, Mitchell SE, Rayner DV, Archer ZA, Dieguez C, Williams LM 2004 Regulation of growth hormone secretagogue receptor gene expression in the arcuate nuclei of the rat by leptin and ghrelin. Diabetes 53:2552-2558 (Pubitemid 39299261)
42. Hewson AK, Tung LY, Connell DW, Tookman L, Dickson SL 2002 The rat arcuate nucleus integrates peripheral signals provided by leptin, insulin, and a ghrelin mimetic. Diabetes 51:3412-3419 (Pubitemid 35403444)
43. Holst B, Schwartz TW 2004 Constitutive ghrelin receptor activity as a signaling set-point in appetite regulation. Trends Pharmacol Sci 25:113-117 (Pubitemid 38264498)
44. Ishii S, Kamegai J, Tamura H, Shimizu T, Sugihara H, Oikawa S 2002 Role of ghrelin in streptozotocin-induced diabetic hyperphagia. Endocrinology 143:4934-4937 (Pubitemid 35397633)
45. Esler WP, Rudolph J, Claus TH, Tang W, Barucci N, Brown SE, Bullock W, Daly M, Decarr L, Li Y, Milardo L, Molstad D, Zhu J, Gardell SJ, Livingston JN, Sweet LJ 2007 Small-molecule ghrelin receptor antagonists improve glucose tolerance, suppress appetite, and promote weight loss. Endocrinology 148:5175-5185 (Pubitemid 350012622)
46. Moulin A, Demange L, Ryan J, Mousseaux D, Sanchez P, Bergé G, Gagne D, Perrissoud D, Locatelli V, Torsello A, Galleyrand JC, Fehrentz JA, Martinez J 2008 New trisubstituted 1,2,4-triazole derivatives as potent ghrelin receptor antagonists. 3. Synthesis and pharmacological in vitro and in vivo evaluations. J Med Chem 51:689-693
47. Arvanitakis L, Geras-Raaka E, Gershengorn MC 1998 Constitutively signaling g-protein-coupled receptors and human disease. Trends Endocrinol Metab 9:27-31 (Pubitemid 28157860)
48. Seifert R, Wenzel-Seifert K 2002 Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wildtype receptors. Naunyn Schmiedebergs Arch Pharmacol 366:381-416 (Pubitemid 35251788)
49. Holst PJ, Rosenkilde MM, Manfra D, Chen SC, Wiekowski MT, Holst B, Cifire F, Lipp M, Schwartz TW, Lira SA 2001 Tumorigenesis induced by the HHV8-encoded chemokine receptor requires ligand modulation of high constitutive activity. J Clin Invest 108:1789-1796 (Pubitemid 34015124)
50. Srinivasan S, Santiago P, Lubrano C, Vaisse C, Conklin BR 2007 Engineering the melanocortin-4 receptor to control constitutive and ligand-mediated G(S) signaling in vivo. PLoS ONE 2:e668 (Pubitemid 351314877)